1. Home
  2. VKTX vs GOLF Comparison

VKTX vs GOLF Comparison

Compare VKTX & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • GOLF
  • Stock Information
  • Founded
  • VKTX 2012
  • GOLF 1910
  • Country
  • VKTX United States
  • GOLF United States
  • Employees
  • VKTX N/A
  • GOLF N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • GOLF Recreational Games/Products/Toys
  • Sector
  • VKTX Health Care
  • GOLF Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • GOLF Nasdaq
  • Market Cap
  • VKTX 2.8B
  • GOLF 4.0B
  • IPO Year
  • VKTX 2015
  • GOLF 2016
  • Fundamental
  • Price
  • VKTX $28.19
  • GOLF $76.00
  • Analyst Decision
  • VKTX Buy
  • GOLF Hold
  • Analyst Count
  • VKTX 12
  • GOLF 6
  • Target Price
  • VKTX $84.00
  • GOLF $70.83
  • AVG Volume (30 Days)
  • VKTX 3.9M
  • GOLF 399.2K
  • Earning Date
  • VKTX 07-23-2025
  • GOLF 08-05-2025
  • Dividend Yield
  • VKTX N/A
  • GOLF 1.24%
  • EPS Growth
  • VKTX N/A
  • GOLF 24.59
  • EPS
  • VKTX N/A
  • GOLF 3.61
  • Revenue
  • VKTX N/A
  • GOLF $2,452,909,000.00
  • Revenue This Year
  • VKTX N/A
  • GOLF $3.94
  • Revenue Next Year
  • VKTX N/A
  • GOLF $1.76
  • P/E Ratio
  • VKTX N/A
  • GOLF $21.07
  • Revenue Growth
  • VKTX N/A
  • GOLF 2.07
  • 52 Week Low
  • VKTX $18.92
  • GOLF $55.31
  • 52 Week High
  • VKTX $81.73
  • GOLF $76.73
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 55.39
  • GOLF 63.23
  • Support Level
  • VKTX $25.80
  • GOLF $72.06
  • Resistance Level
  • VKTX $28.80
  • GOLF $76.73
  • Average True Range (ATR)
  • VKTX 1.65
  • GOLF 1.84
  • MACD
  • VKTX 0.11
  • GOLF 0.28
  • Stochastic Oscillator
  • VKTX 86.93
  • GOLF 86.24

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

Share on Social Networks: